Clinical Trials Directory

Trials / Unknown

UnknownNCT00828360

Dobutamine Stress Echocardiography in Cardiac Resynchronization Therapy (CRT) Patients Selection

Efficacy Of Low-Dose Dobutamine Stress-Echocardiography To Predict Cardiac Resynchronization Therapy Response

Status
Unknown
Phase
Study type
Observational
Enrollment
270 (estimated)
Sponsor
Ospedale Santa Maria di Loreto Mare · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

While cardiac resynchronization therapy (CRT) has a well demonstrated therapeutic effect in selected patients with advanced heart failure (HF) on optimized drug therapy, non-responder rate remains high. The low-dose dobutamine stress-echo (DSE) test to predict positive response to CRT (LODO-CRT) trial is designed to improve patient selection for CRT.

Detailed description

LODO-CRT is a multicenter prospective study enrolling HF patients with conventional indication to CRT (symptomatic stable NYHA class III-IV on optimized drug therapy, QRS≥120 msec, left ventricular (LV) dilatation, LVEF≤35%) is designed to assess the predictive value of LV contractile reserve (LVCR), determined through DSE, in predicting CRT response during follow-up. Assessment of CRT effects will follow two sequential phases: in phase 1 CRT response end-point is defined as left ventricular end-systolic volume (LVESV) reduction ≥ 10% at 6 months; in phase 2, both LVESV reduction and clinical status via a clinical composite score will be evaluated at 12 months follow-up. Predictive value of LVCR will be compared to other measures, such as LV dyssynchrony measures, through adjusted multivariable analysis. For the purpose of the study, target patient number is 270 patients (with 95% confidence, 80% power, α≤0.05). LVCR assessment, using low-dose DES test, should effectively predict positive response to CRT both in terms of the reverse remodeling process as well as favorable long-term clinical outcome. Moreover, the predictive value of LVCR will be compared to that of conventional intra-LV dyssynchrony measures.

Conditions

Timeline

Start date
2006-07-01
Primary completion
2009-04-01
Completion
2009-09-01
First posted
2009-01-23
Last updated
2009-01-23

Locations

5 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT00828360. Inclusion in this directory is not an endorsement.